Published in Hepatitis Weekly, February 5th, 2001
Those recipients should either be anti-HBc+ or anti-hepatitis B surface antigen positive (anti-HBs+), according authors of the study, who performed their analysis at the University Hospital of La Fe in Valencia, Spain.
The geographical region where the evaluation took place has a high rate of anti-HBc+ in the population. Martin Prieto,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly